Clinical Trials Browser

Uterine Cervical Neoplasms

Brain Neoplasms, Glioblastoma

Prostatic Neoplasms

Carcinoma, Hepatocellular

Anatomic Stage I Breast Cancer AJCC v8

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Glioblastoma

Carcinoma, Hepatocellular

Lymphoma, B-Cell

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Carcinoma, Adenoid Cystic

Breast Neoplasms, Triple Negative Breast Neoplasms

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Transitional Cell

Glioblastoma, Gliosarcoma

Neoplasm Metastasis

Prostatic Neoplasms

Glioblastoma, Glioma

Stomach Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Serotonin Syndrome

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung, Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Lymphoma, Non-Hodgkin

Brain Neoplasms, Glioma

Carcinoma, Lobular

Prostatic Neoplasms

Glioblastoma

Biochemically Recurrent Prostate Carcinoma

Glioblastoma

Glioblastoma

Neurofibromatosis 1, Neurofibrosarcoma

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Head and Neck Neoplasms, Neoplasms, Pancreatic Neoplasms

Colorectal Neoplasms

Breast Neoplasms, Calcinosis

Prostatic Neoplasms

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Clinical Trials

TEP-Curie

UC-GlioFET

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

HYPONECK

EVA DOPA

68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

NYM

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer

Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma

18F-DOPA-PET in Planning Surgery in Patients With Gliomas

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Resting-State Functional MRI in Glioma Patients Before and After Surgery

18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

IMPACT

Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer

64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

PET Scan in Treating Patients With Metastatic Prostate Cancer

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression